To improve the knowledge on the fundamental mechanisms used by SHP1 to deregulate liver cells pushing the onset of HCV-related liver cancer, may give novel preventive or therapeutic strategy to counteract HCV-related HCC. This evidence concerns the gene NR0B2 and hepatocellular carcinoma.